ASO Author Reflections: Prediction of the Response to Neoadjuvant Therapy by Patients with Esophageal Squamous Cell Carcinoma

被引:1
作者
Okamura, Akihiko [1 ]
Watanabe, Masayuki [1 ]
Okui, Jun [2 ,3 ]
Matsuda, Satoru [3 ]
Takemura, Ryo [4 ]
Kawakubo, Hirofumi [3 ]
Takeuchi, Hiroya [5 ]
Muto, Manabu [6 ]
Kakeji, Yoshihiro [7 ]
Kitagawa, Yuko [3 ]
Doki, Yuichiro [8 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Gastroenterol Ctr, Dept Esophageal Surg, Tokyo, Japan
[2] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Surg, Tokyo, Japan
[4] Keio Univ Hosp, Clin & Translat Res Ctr, Biostat Unit, Tokyo, Japan
[5] Hamamatsu Univ Sch Med, Dept Surg, Hamamatsu, Shizuoka, Japan
[6] Kyoto Univ, Dept Therapeut Oncol, Grad Sch Med, Kyoto, Japan
[7] Kobe Univ, Grad Sch Med, Dept Surg, Div Gastrointestinal Surg, Kobe, Hyogo, Japan
[8] Osaka Univ, Dept Gastroenterol Surg, Grad Sch Med, Osaka, Japan
关键词
D O I
10.1245/s10434-022-12962-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2186 / 2187
页数:2
相关论文
共 5 条
[1]   A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant [J].
Kato, Ken ;
Ito, Yoshinori ;
Daiko, Hiroyuki ;
Ozawa, Soji ;
Ogata, Takashi ;
Hara, Hiroki ;
Kojima, Takashi ;
Abe, Tetsuya ;
Bamba, Takeo ;
Watanabe, Masaya ;
Kawakubo, Hirofumi ;
Shibuya, Yuichi ;
Tsubosa, Yasuhiro ;
Takegawa, Naoki ;
Kajiwara, Takeshi ;
Baba, Hideo ;
Ueno, Masaki ;
Machida, Ryunosuke ;
Nakamura, Kenichi ;
Kitagawa, Yuko .
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
[2]   Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1 [J].
Kitagawa, Yuko ;
Uno, Takashi ;
Oyama, Tsuneo ;
Kato, Ken ;
Kato, Hiroyuki ;
Kawakubo, Hirofumi ;
Kawamura, Osamu ;
Kusano, Motoyasu ;
Kuwano, Hiroyuki ;
Takeuchi, Hiroya ;
Toh, Yasushi ;
Doki, Yuichiro ;
Naomoto, Yoshio ;
Nemoto, Kenji ;
Booka, Eisuke ;
Matsubara, Hisahiro ;
Miyazaki, Tatsuya ;
Muto, Manabu ;
Yanagisawa, Akio ;
Yoshida, Masahiro .
ESOPHAGUS, 2019, 16 (01) :1-24
[3]  
Kitagawa Y, 2019, ESOPHAGUS-TOKYO, V16, P25, DOI 10.1007/s10388-018-0642-8
[4]  
Okamura A, 2023, ANN SURG ONCOL, V30, P2176, DOI 10.1245/s10434-022-12960-9
[5]   Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis [J].
Sjoquist, Katrin M. ;
Burmeister, Bryan H. ;
Smithers, B. Mark ;
Zalcberg, John R. ;
Simes, R. John ;
Barbour, Andrew ;
Gebski, Val .
LANCET ONCOLOGY, 2011, 12 (07) :681-692